[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITMI20021399A1 - Inibitori della cicloossigenasi 2 - Google Patents

Inibitori della cicloossigenasi 2

Info

Publication number
ITMI20021399A1
ITMI20021399A1 IT2002MI001399A ITMI20021399A ITMI20021399A1 IT MI20021399 A1 ITMI20021399 A1 IT MI20021399A1 IT 2002MI001399 A IT2002MI001399 A IT 2002MI001399A IT MI20021399 A ITMI20021399 A IT MI20021399A IT MI20021399 A1 ITMI20021399 A1 IT MI20021399A1
Authority
IT
Italy
Prior art keywords
cyclooxygenase inhibitors
cyclooxygenase
inhibitors
Prior art date
Application number
IT2002MI001399A
Other languages
English (en)
Inventor
Giancarlo Santus
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to IT2002MI001399A priority Critical patent/ITMI20021399A1/it
Publication of ITMI20021399A0 publication Critical patent/ITMI20021399A0/it
Priority to PCT/EP2003/006651 priority patent/WO2004000300A1/en
Priority to AU2003238042A priority patent/AU2003238042A1/en
Publication of ITMI20021399A1 publication Critical patent/ITMI20021399A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002MI001399A 2002-06-25 2002-06-25 Inibitori della cicloossigenasi 2 ITMI20021399A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002MI001399A ITMI20021399A1 (it) 2002-06-25 2002-06-25 Inibitori della cicloossigenasi 2
PCT/EP2003/006651 WO2004000300A1 (en) 2002-06-25 2003-06-24 Cyclooxygenase-2 inhibitors
AU2003238042A AU2003238042A1 (en) 2002-06-25 2003-06-24 Cyclooxygenase-2 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001399A ITMI20021399A1 (it) 2002-06-25 2002-06-25 Inibitori della cicloossigenasi 2

Publications (2)

Publication Number Publication Date
ITMI20021399A0 ITMI20021399A0 (it) 2002-06-25
ITMI20021399A1 true ITMI20021399A1 (it) 2003-12-29

Family

ID=11450085

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001399A ITMI20021399A1 (it) 2002-06-25 2002-06-25 Inibitori della cicloossigenasi 2

Country Status (3)

Country Link
AU (1) AU2003238042A1 (it)
IT (1) ITMI20021399A1 (it)
WO (1) WO2004000300A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2487414A1 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1534683A4 (en) 2002-06-27 2005-08-24 Nitromed Inc CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHOD OF USE
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
AU2003252515A1 (en) 2002-07-26 2004-02-16 Merck Frosst Canada And Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
US7169809B2 (en) 2003-03-05 2007-01-30 Merck Frosst Company Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
BRPI0515218A (pt) 2004-08-26 2008-07-08 Nicholas Piramal India Ltd composto, composição farmacêutica, método para o tratamento de um mamìfero ou ser humano, método de uso do composto, novos intermediários, uso dos novos intermediários, processo para a preparação de um composto
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
US7521435B2 (en) 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
CA2630805A1 (en) * 2005-11-23 2007-05-31 Nicox S.A. Salicylic acid derivatives
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
MX2009013136A (es) 2007-06-04 2010-04-30 Techfields Inc Profarmacos de nsaias con piel y membranas con indices de penetracion muy altos y nuevos usos medicinales.
CN101868443A (zh) 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-苯基邻氨基苯甲酸衍生物及其用途
WO2009037705A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
KR102225999B1 (ko) 2008-12-04 2021-03-10 충시 위 고투과력을 가진 조성물 및 이의 적용
KR102309973B1 (ko) 2012-01-18 2021-10-06 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
CN102964250A (zh) * 2012-11-19 2013-03-13 吉林大学 氟比洛芬丁香酚酯药用化合物及其制剂和制备方法
US9227962B2 (en) 2013-03-13 2016-01-05 Boston Biomedical, Inc. Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
US9187454B2 (en) * 2013-03-13 2015-11-17 Boston Biomedical, Inc. Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759899B1 (en) * 1994-05-10 1999-09-15 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
IT1308633B1 (it) * 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319202B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie

Also Published As

Publication number Publication date
ITMI20021399A0 (it) 2002-06-25
WO2004000300A1 (en) 2003-12-31
AU2003238042A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
DE60234125D1 (de) E inhibitoren
NO2018012I2 (no) Padeliporfin
ITMI20021399A1 (it) Inibitori della cicloossigenasi 2
DE50303193D1 (de) Übertrager
NO20044046L (no) Substituerte hydroksyetylaminer
DE60305663D1 (de) Kippschirm
DE60333177D1 (de) Zünder
NO20043944L (no) Pyrrologyrimidinderivater
NO20044007L (no) Skjaerelokaliseringsverktoy
DE60335555D1 (de) Enstands
NO20040429L (no) Stromningsrorisolasjonssystem
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
DE60302827D1 (de) Hochgeschwindigheitfräsmaschine
DE60229669D1 (de) X-2 inhibitoren
DE60307471D1 (de) Hemmung
DE60335246D1 (de) Gewebsreparaturmatrix
DE50310701D1 (de) Magnetfuehrungseinrichtung
NO20033410L (no) Pressverktoy
ITMI20021327A1 (it) Nuove ossialchilpiperazine
DE60321209D1 (de) N-sulfonylaminothiazole
ATE350379T1 (de) Substituierte benzdioxepine
DE50310191D1 (de) Zwischenspeicher
DE50311554D1 (de) Filterhalter